Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.160
+0.060 (5.45%)
At close: Dec 19, 2025, 4:00 PM EST
1.100
-0.060 (-5.18%)
After-hours: Dec 19, 2025, 7:57 PM EST
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $25.98 million as of December 19, 2025. Its market cap has increased by 605.04% in one year.
Market Cap
25.98M
Enterprise Value
21.86M
1-Year Change
605.04%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $25.98M, a decrease of -60.21%. That is a compound annual growth rate of -19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 25.98M | 551.32% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |